The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
EAHP Policy Call 10th October 2016
1) CTF
WG1
Final finessing of consultation draft underway. AB gave a further deadline of 10th October for final remarks from WG1 members.
WG2
Lorna, Nenad and Cornelia leading in completion of paper.
WG3
To discuss dynamics of consultation (timings, form etc).
Draft recruitment strategy here.
Recent JP comments on recruitment here.
Report back from SEFH Congress (4th-7th October)
Look ahead to Italy Congress (2nd-4th December).
(Also Czech Congress in November)
2) FMD
Recent Written response of Commission here.
To also discuss proposed activity with members (arising from September Board Meeting discussions).
3) Shortages
To discuss Bratislava Health Ministers’ meeting, and follow up (i.e. letters to Commissioner and Slovak Health Minister).
To discuss Draft European Parliament Access Report, and proposed amendments.
To discuss recent COST Action and promotion activities.
To discuss research needs.
4) Consultations
- Commission consultation on the concept of similar medicinal product in the context of orphan legislation.
- 3 EMA Pharmacovigilance consultations
Any major points to raise?
- European Commission consultation on clinical trials in developing countries
Consultation here. Deadline 15th October. Any particular points to raise?
- European Commission consultation on European Pillar on Social Rights
Consultation here. Deadline 31 December. Some NGOs becoming energised about conveying the need for an EU more involved in health.
5) EMA Matters
8th December Workshop on Adaptive Pathways.
6) Misc
To discuss:
– Off Label Use
– Jeffrey Atkinson request (and Phar-QA)
7) Future events
To note:
Thursday 13th October, Health First Europe Patient Safety event. Invitation here. To see referenced ‘Patient Safety Policy Indicators’ here.
Thursday 13th-14th October, Phar-QA meeting
Tuesday 25th October – FIPRA Biologics Meeting (FJ to attend)
Tuesday 15th November – PGEU event in the European Parliament. More information here.